A69T (p.Ala69Thr) variant of FBN2 (Fibrillin-2)

A69T (p.Ala69Thr) in FBN2 (Fibrillin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

A69T (p.Ala69Thr) variant details